Allen Baharaff

CEO

Equibles does not estimate personal net worth.

Get an email with a short summary when EoCene Ltd. publishes a filing, an earnings call transcript or a press release.

About Allen Baharaff

Allen Baharaff is recorded as CEO at EoCene Ltd. (EOCN). Allen Baharaff has spoken on 7 earnings calls across 1 company, most recently for EoCene Ltd. on December 31, 2021. EoCene Ltd. is classified in the Biotechnology industry within the Healthcare sector.

Allen Baharaff on recent calls

“I am pleased to be here today with our Chief Scientific Officer, Dr. Liat Hayardeny, our Chief Financial Officer, Doron Cohen, and Chief Accounting Officer, Yohai Stenzler to provide you with an update on our clinical development programs, as well as report on our financial results for the 2021 fourth quarter and full…”

CEO, Galmed Pharmaceuticals Ltd. Q4 FY2021 Earnings Call · December 31, 2021

“I am pleased to be here today with our Chief Scientific Officer, Dr. Liat Hayardeny and our Chief Financial Officer, Yohai Stenzler. We are also grateful to have with us today our guest KOL Professor Vlad Ratziu from the Sorbonne Université and ARMOR study Co-Principal Investigator.”

CEO, Galmed Pharmaceuticals Ltd. Q3 FY2021 Earnings Call · November 8, 2021

“I am pleased to be here today with our Chief Scientific Officer, Dr. Liat Hayardeny, and our Chief Financial Officer, Yohai Stenzler, to provide you with an update on our clinical development programs as well as to report on our financial results for the second quarter of 2021.”

CEO, Galmed Pharmaceuticals Ltd. Q2 FY2021 Earnings Call · August 5, 2021

“I'm pleased to be here today with our Chief Scientific Officer, Dr. Liat Hayardeny; and our Chief Financial Officer, Yohai Stenzler, to provide you with an update on our clinical development programs as we report to you on our financial results for the first quarter of 2021.”

CEO, Galmed Pharmaceuticals Ltd. Q1 FY2021 Earnings Call · May 13, 2021

“I'm pleased to be here with our Chief Scientific Officer, Dr. Liat Hayardeny, and our Chief Financial Officer, Yohai Stenzler, to update you on our clinical development programs and report on our financial results for the fourth quarter and year-end of 2020.”

CEO, Galmed Pharmaceuticals Ltd. Q4 FY2020 Earnings Call · March 18, 2021